GPT and metabolic dysfunction-associated steatotic liver disease: In the NAFLD group, the body mass index (BMI) (30.1 vs. 27.5 kg/m2; p < 0.001), Triglyceride (TG) (165 vs. 126 mg/dl; P = 0.002), AST (20.5 vs. 19IU/l; P = 0.03), ALT (25 vs. 18 IU/l; P < 0.001), dyslipidemia prevalence (95.8 vs. 81.3%; P = 0.006), and CAP score (326 vs. 266Db/M; p < 0.001) were significantly higher than those without NAFLD.